Casdin Capital’s Alnylam Pharmaceuticals ALNY Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $26.6M | Sell |
81,500
-38,500
| -32% | -$12.6M | 2.42% | 9 |
|
2025
Q1 | $32.4M | Sell |
120,000
-20,000
| -14% | -$5.4M | 2.65% | 8 |
|
2024
Q4 | $32.9M | Sell |
140,000
-30,000
| -18% | -$7.06M | 2.19% | 11 |
|
2024
Q3 | $46.8M | Hold |
170,000
| – | – | 3.12% | 9 |
|
2024
Q2 | $41.3M | Sell |
170,000
-188,000
| -53% | -$45.7M | 3.15% | 10 |
|
2024
Q1 | $53.5M | Buy |
358,000
+163,000
| +84% | +$24.4M | 3.98% | 6 |
|
2023
Q4 | $37.3M | Sell |
195,000
-5,000
| -3% | -$957K | 3.66% | 9 |
|
2023
Q3 | $35.4M | Sell |
200,000
-80,000
| -29% | -$14.2M | 3.92% | 9 |
|
2023
Q2 | $53.2M | Buy |
280,000
+10,000
| +4% | +$1.9M | 4.65% | 5 |
|
2023
Q1 | $54.1M | Sell |
270,000
-95,000
| -26% | -$19M | 4.46% | 6 |
|
2022
Q4 | $86.7M | Sell |
365,000
-283,000
| -44% | -$67.3M | 6.72% | 4 |
|
2022
Q3 | $130M | Sell |
648,000
-157,000
| -20% | -$31.4M | 8.52% | 4 |
|
2022
Q2 | $117M | Sell |
805,000
-195,000
| -20% | -$28.4M | 9.93% | 2 |
|
2022
Q1 | $163M | Hold |
1,000,000
| – | – | 7.32% | 2 |
|
2021
Q4 | $170M | Hold |
1,000,000
| – | – | 4.78% | 5 |
|
2021
Q3 | $189M | Hold |
1,000,000
| – | – | 4.7% | 6 |
|
2021
Q2 | $170M | Buy |
1,000,000
+120,000
| +14% | +$20.3M | 4.3% | 7 |
|
2021
Q1 | $124M | Buy |
880,000
+100,000
| +13% | +$14.1M | 3.7% | 7 |
|
2020
Q4 | $101M | Buy |
780,000
+160,000
| +26% | +$20.8M | 3% | 11 |
|
2020
Q3 | $90.3M | Buy |
620,000
+70,000
| +13% | +$10.2M | 4.04% | 7 |
|
2020
Q2 | $81.5M | Sell |
550,000
-35,000
| -6% | -$5.18M | 4.82% | 6 |
|
2020
Q1 | $63.7M | Buy |
585,000
+70,000
| +14% | +$7.62M | 6.76% | 3 |
|
2019
Q4 | $59.3M | Sell |
515,000
-85,000
| -14% | -$9.79M | 5.45% | 6 |
|
2019
Q3 | $48.3M | Sell |
600,000
-50,000
| -8% | -$4.02M | 4.99% | 9 |
|
2019
Q2 | $47.2M | Buy |
650,000
+205,000
| +46% | +$14.9M | 4.41% | 10 |
|
2019
Q1 | $41.6M | Buy |
445,000
+90,000
| +25% | +$8.41M | 4.57% | 10 |
|
2018
Q4 | $25.9M | Buy |
355,000
+85,000
| +31% | +$6.2M | 4.43% | 11 |
|
2018
Q3 | $23.6M | Hold |
270,000
| – | – | 2.87% | 17 |
|
2018
Q2 | $26.6M | Buy |
270,000
+20,000
| +8% | +$1.97M | 3.72% | 12 |
|
2018
Q1 | $29.8M | Buy |
250,000
+50,000
| +25% | +$5.96M | 5.24% | 7 |
|
2017
Q4 | $25.4M | Hold |
200,000
| – | – | 6.19% | 6 |
|
2017
Q3 | $23.5M | Buy |
200,000
+95,000
| +90% | +$11.2M | 6.64% | 3 |
|
2017
Q2 | $8.38M | Buy |
105,000
+50,000
| +91% | +$3.99M | 3.1% | 11 |
|
2017
Q1 | $2.82M | Sell |
55,000
-30,000
| -35% | -$1.54M | 1.66% | 24 |
|
2016
Q4 | $3.18M | Buy |
85,000
+46,000
| +118% | +$1.72M | 2.63% | 16 |
|
2016
Q3 | $2.64M | Sell |
39,000
-33,500
| -46% | -$2.27M | 2.14% | 16 |
|
2016
Q2 | $4.02M | Sell |
72,500
-17,500
| -19% | -$971K | 4% | 10 |
|
2016
Q1 | $5.65M | Buy |
90,000
+30,000
| +50% | +$1.88M | 6.48% | 7 |
|
2015
Q4 | $5.65M | Buy |
+60,000
| New | +$5.65M | 4.99% | 11 |
|